Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Timolol - Generic Drug Details

« Back to Dashboard

What are the generic sources for timolol and what is the scope of timolol freedom to operate?

is the generic ingredient in eight branded drugs marketed by Akorn, Oak Pharms Inc, Usl Pharma, Apotex Inc, Bausch And Lomb, Merck, Watson Labs, Valeant Pharms Llc, Pacific Pharma, Teva, Sandoz, Fdc Ltd, Sandoz Inc, Hi Tech Pharma, Aton, Quantum Pharmics, Fougera, Mylan, and Wockhardt, and is included in forty-five NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for timolol. Three suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: timolol

Drug Master File Entries: see list15
Suppliers / Packagers: see list3
Bulk Api Vendors: see list23
Clinical Trials: see list96
Patent Applications: see list6,863
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:timolol at DailyMed

Pharmacology for Ingredient: timolol

Tentative approvals for TIMOLOL

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe0.5%SOLUTION;OPHTHALMIC
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
timolol maleate
TABLET;ORAL018017-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
timolol maleate
SOLUTION/DROPS;OPHTHALMIC074667-001Mar 25, 1997DISCNNoNo► Subscribe► Subscribe
timolol maleate
SOLUTION/DROPS;OPHTHALMIC074515-001Mar 25, 1997DISCNNoNo► Subscribe► Subscribe
Oak Pharms Inc
SOLUTION/DROPS;OPHTHALMIC020439-001Mar 31, 1995ATRXYesYes► Subscribe► Subscribe
Quantum Pharmics
timolol maleate
TABLET;ORAL072466-001May 19, 1989DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus